EQUILLIUM, INC. Proceeds from Maturities, Prepayments and Calls of Short-term Investments
EQUILLIUM, INC. (EQ) reported Proceeds from Maturities, Prepayments and Calls of Short-term Investments of $4.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments · last filed 2026-08-13
- EQUILLIUM, INC. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- EQUILLIUM, INC. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- EQUILLIUM, INC. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- EQUILLIUM, INC. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2025-03-31 was $4.50M, a 0.00% change year-over-year.
- EQUILLIUM, INC. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2025 was $4.50M, a 85.71% decline from fiscal 2024.
- EQUILLIUM, INC. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2024 was $31.50M, a 37.00% decline from fiscal 2023.
- EQUILLIUM, INC. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2023 was $50.00M, a 50.49% increase from fiscal 2022.
- EQUILLIUM, INC. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2022 was $33.23M, a 45.04% decline from fiscal 2021.
| Period end | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 3 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 6 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 9 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $4.50M 10-K · filed 2026-03-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $4.50M 10-Q · filed 2025-11-13 | $10.50M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $4.50M 10-Q · filed 2026-08-13 | $10.50M derived: sum of 3 quarters · filed 2026-08-13 | $22.50M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $4.50M 10-Q · filed 2026-05-13 | $10.50M derived: sum of 2 quarters · filed 2026-05-13 | $22.50M derived: sum of 3 quarters · filed 2026-05-13 | $31.50M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $18.00M derived: sum of 2 quarters · filed 2026-03-25 | $27.00M derived: sum of 3 quarters · filed 2026-03-25 | $31.50M 10-K · filed 2026-03-25 |
| 2024-09-30 | $12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $21.00M derived: sum of 2 quarters · filed 2025-11-13 | $25.50M 10-Q · filed 2025-11-13 | $37.50M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $13.50M 10-Q · filed 2025-08-14 | $25.50M derived: sum of 3 quarters · filed 2025-08-14 | $36.50M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $4.50M 10-Q · filed 2025-05-14 | $16.50M derived: sum of 2 quarters · filed 2025-05-14 | $27.50M derived: sum of 3 quarters · filed 2025-05-14 | $42.50M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $23.00M derived: sum of 2 quarters · filed 2025-03-27 | $38.00M derived: sum of 3 quarters · filed 2025-03-27 | $50.00M 10-K · filed 2025-03-27 |
| 2023-09-30 | $11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $26.00M derived: sum of 2 quarters · filed 2024-11-13 | $38.00M 10-Q · filed 2024-11-13 | $44.98M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $27.00M 10-Q · filed 2024-08-08 | $33.98M derived: sum of 3 quarters · filed 2024-08-08 | $48.98M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $12.00M 10-Q · filed 2024-05-09 | $18.98M derived: sum of 2 quarters · filed 2024-05-09 | $33.98M derived: sum of 3 quarters · filed 2024-05-09 | $42.73M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $6.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $21.98M derived: sum of 2 quarters · filed 2024-03-25 | $30.73M derived: sum of 3 quarters · filed 2024-03-25 | $33.23M 10-K · filed 2024-03-25 |
| 2022-09-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $23.75M derived: sum of 2 quarters · filed 2023-11-08 | $26.25M 10-Q · filed 2023-11-08 | $28.75M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $8.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $11.24M 10-Q · filed 2023-08-09 | $13.74M derived: sum of 3 quarters · filed 2023-08-09 | $30.25M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $2.50M 10-Q · filed 2023-05-11 | $5.00M derived: sum of 2 quarters · filed 2023-05-11 | $21.50M derived: sum of 3 quarters · filed 2023-05-11 | $50.49M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $19.00M derived: sum of 2 quarters · filed 2023-03-23 | $47.99M derived: sum of 3 quarters · filed 2023-03-23 | $60.45M 10-K · filed 2023-03-23 |
| 2021-09-30 | $16.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $45.49M derived: sum of 2 quarters · filed 2022-11-14 | $57.95M 10-Q · filed 2022-11-14 | $66.14M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $28.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $41.45M 10-Q · filed 2022-08-15 | $49.65M derived: sum of 3 quarters · filed 2022-08-15 | $54.88M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $12.46M 10-Q · filed 2022-05-12 | $20.66M derived: sum of 2 quarters · filed 2022-05-12 | $25.89M derived: sum of 3 quarters · filed 2022-05-12 | $34.34M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $8.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $13.42M derived: sum of 2 quarters · filed 2022-03-23 | $21.88M derived: sum of 3 quarters · filed 2022-03-23 | $37.12M 10-K · filed 2022-03-23 |
| 2020-09-30 | $5.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $13.69M derived: sum of 2 quarters · filed 2021-11-10 | $28.93M 10-Q · filed 2021-11-10 | $42.14M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $8.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $23.70M 10-Q · filed 2021-08-10 | $36.91M derived: sum of 3 quarters · filed 2021-08-10 | $47.15M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $15.24M 10-Q · filed 2021-05-13 | $28.46M derived: sum of 2 quarters · filed 2021-05-13 | $38.70M derived: sum of 3 quarters · filed 2021-05-13 | $56.20M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $13.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $23.45M derived: sum of 2 quarters · filed 2021-03-24 | $40.95M derived: sum of 3 quarters · filed 2021-03-24 | $52.53M 10-K · filed 2021-03-24 |
| 2019-09-30 | $10.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $27.74M derived: sum of 2 quarters · filed 2020-11-10 | $39.31M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $17.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $29.07M 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | $11.57M 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |